Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature

Keyphrases

• Inflammatory Bowel Disease 100%
• Novel Therapies 100%
• Interleukin-27 (IL-27) 100%
• Mouse Model 20%
• United States 10%
• Clinical Trials 10%
• Pathophysiology 10%
• Etiology 10%
• Inflammatory Disorders 10%
• Remission 10%
• Infectious Diseases 10%
• Conflicting Results 10%
• Genomic Deletion 10%
• Intestine 10%
• Autoimmunity 10%
• IL-1 Family Cytokines 10%
• Virus-associated Cancer 10%
• Anti-tumor Necrosis Factor Therapy 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Interleukin 27 100%
• Cytokine 30%
• Mouse Model 20%
• Malignant Neoplasm 10%
• Disease 10%
• Clinical Trial 10%
• Receptor 10%
• Tumor Necrosis Factor 10%
• Pathophysiology 10%
• Infection 10%
• Remission 10%

Immunology and Microbiology

• Inflammatory Bowel Disease 100%
• Interleukin 27 100%
• Cytokine 30%
• Mouse Model 20%
• Tumor Necrosis Factor 10%
• Inflammatory Disorder 10%
• Intestine 10%
• Gene Deletion 10%
• Infectious Disease 10%
• Autoimmunity 10%